Alibaba Health Information Technology
TOPIC
 / company

Alibaba Health Information Technology

(阿里健康信息技术有限公司)

Related Topics:
Alibaba Health Information Technology
Alibaba Health Information Technology
阿里健康信息技术有限公司
Alibaba Health is the flagship healthcare platform of Alibaba Group Holding. Through two direct online stores, it sells prescription and over-the-counter medications, health supplements and skincare products to customers, who can also access its online consultation service. The company was formerly known as Citic 21CN, a drug data services company. In 2014, Alibaba and a Chinese private equity firm co-founded by Alibaba founder Jack Ma bought a controlling stake in Citic 21CN and changed its name. Alibaba also owns the South China Morning Post.
Chairman / President
Shunyan Zhu
CFO / Finance Director
Tu Yanwu
Industry
Health
Website
alihealth.cn
Headquarters address
Beijing
Stock Code
SEHK: 241
Year founded
2014
The spin-off would result in 3SBio completely exiting its stake in Mandi. Photo: SMCP
Banking & finance

3SBio spin-off Mandi banks on hair-loss and weight-loss drugs in Hong Kong IPO

As 3SBio lines up a Hong Kong spin-off for its hair-loss unit Mandi, the subsidiary is preparing a drug pipeline aimed at acne and obesity.

Hong Kong stock market

Alibaba surge leads Hong Kong stocks to biggest gain in 2 weeks

Alibaba

Alibaba seeks US$1.5 billion from exchangeable bonds for cloud, e-commerce push

videocam
Hong Kong stock market

Hong Kong stocks gain on earnings boost as Meituan beats market consensus

Gains limited by losses in leading carmakers amid lingering concerns about a prolonged price war.

videocam
Exchange Square in Central. Hong Kong. Photo: Sam Tsang
Hong Kong stock market

Stocks slip as China lockdown hits manufacturing base while BYD halts rout

Stocks slipped deeper into a five-month low after China locked down another manufacturing base to control an outbreak. BYD halted a six-day rout on technical rebound.

videocam
Hong Kong stock market

Fear of crackdown on Chinese pharma platforms roils healthcare stocks

Chinese healthcare stocks plunged in Hong Kong after Chinese media reported that Beijing is mulling a ban on sales of medicines on third-party e-commerce platforms.

Advertisement
Advertisement
Advertisement
Stocks

Hong Kong stocks rise for second day as traders pick up tech bargains

Stocks gained for a second day, as bargain-hunting for technology companies continued and a retreat in oil prices eased inflation pressure.

Hong Kong stocks rose for a second day, as bargain-hunting for technology companies continued and a retreat in oil prices eased inflation pressure. Photo: AFP
Stocks

Hang Seng jumps as Alibaba Health, Kuaishou aid tech’s best run in a month

Local stocks capped a three-day winning run as investors found deep values among Big Tech trading near an all-time low. China Life Insurance and developer Modern Land tumbled on internal crises. HSBC also gained.

videocam
Hong Kong stock market

Hang Seng drops on Alibaba Health’s losses while default stuns developers

Stocks declined as the current earnings season offered little sparks, with Alibaba Health warning of impending losses. Modern Land reneged on a dollar bond repayment.

videocam
Hang Seng Index

Alibaba Health, Longfor and Haidilao to join Hong Kong’s benchmark stock index

The Hang Seng Index will add in three more stocks, potentially paving the way for a further expansion to 80 from 55, brokers say.

videocam
A electric monitor shows the Hang Seng Index in Central, Hong Kong. Photo: Sam Tsang
China technology

Alibaba Health stock jumps as Covid-19 fuels first profits since listing

Alibaba Health recorded first-half earnings of US$42.4 million, its first profitable report since 2015, with Covid-19 fuelling awareness and demand for its goods and services.

videocam
A robot retrieving medicines in the pharmacy of the Argenteuil hospital, in Argenteuil, a Paris suburb, as technology changes how business and services are delivered in pandemic. Photo: AFP
Stocks

Alibaba Health’s new share offer attracts strong demand from investors

Alibaba Group’s flagship health care platform completes US$1.3 billion new share sale, marking biggest ever health care follow-on offering in Hong Kong.

videocam
US-listed Chinese stocks

Alibaba Health raising US$1 billion through new share sale for expansion

Alibaba Group’s flagship health care platform will sell 400 million new shares priced between HK$20.05-HS$20.50 each to raise up to the equivalent of US$1.06 billion, according to deal’s term sheet.

videocam
US-listed Chinese stocks

Alibaba Health’s net loss drops 92 per cent as online drug purchases rise

Alibaba Health said on Wednesday it would strengthen partnerships with upstream pharmaceutical companies to further expand its direct online drug sales, after reporting a narrower net loss for the full year of 2019, thanks to wider adoption of online drug purchases during the coronavirus pandemic.

Alibaba Health is the flagship health care platform of Alibaba Group Holding . Photo: Reuters
US-listed Chinese stocks

Alibaba Health offers online advice to overseas Chinese amid coronavirus

Using the Alipay app, overseas Chinese can get in touch with doctors in mainland China for free health care consultations

Tourists wearing masks seen in the Asakusa district of Tokyo, Japan, March 5, 2020. Overseas Chinese can use AliPay to get free online consultations with doctors in mainland China. Photo: EPA-EFE
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement